Patent intelligence · US
US 8187606
HPV antigen fusion protein vaccine compositions and uses thereof
HPV antigen fusion protein vaccine compositions and uses thereof
Patent details — US 8187606
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 29, 2012
- Expiration
- May 24, 2032
- Applicant
- Beijing Sunbio Biotech Co. Ltd.
- Claims
- 14
- CPC classes
- A61K, A61K2039/585, A61K2039/6031, A61K39/12
Quick answer
US 8187606 (HPV antigen fusion protein vaccine compositions and uses thereof) is held by Beijing Sunbio Biotech Co. Ltd.. Status: granted. Granted May 29, 2012. Expires May 24, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Beijing Sunbio Biotech Co. Ltd.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K2039/585, A61K2039/6031, A61K39/12, A61P, A61P17/12
More from Beijing Sunbio Biotech Co. Ltd.
Related pharmaceutical patents in our USPTO index.
-
US 12234288
Immunogenic arginase 2 polypeptides
granted -
US 12233103
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 12215135
PDL2 compounds
granted -
US 12194081
ARGINASE1 polypeptides
granted -
US 12187782
PDL1 peptides for use in cancer vaccines
granted -
US 12077785
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof
granted -
US 11981944
Immunogenic arginase peptides
granted -
US 11878053
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof
granted
Frequently asked questions
What is US patent 8187606?
US 8187606 (HPV antigen fusion protein vaccine compositions and uses thereof) is held by Beijing Sunbio Biotech Co. Ltd.. Status: granted. Granted May 29, 2012. Expires May 24, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8187606?
Beijing Sunbio Biotech Co. Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 21 pharmaceutical patents for this assignee.
When does US 8187606 expire?
Our index shows an expiration date of May 24, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.